Literature DB >> 1541768

Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients.

J C Markowitz1, M E Moran, J H Kocsis, A J Frances.   

Abstract

We investigated prevalence and comorbidity of DSM-III dysthymic disorder in a psychiatric outpatient clinic. Seventy-five consecutive outpatients received structured interviews. Prevalence of dysthymic disorder was 36% in the consecutive sample. Thirty-four dysthymic and 56 non-dysthymic patients were compared for comorbidity. Dysthymic subjects were more likely to meet criteria for major depression, social phobia, and avoidant, self-defeating, dependent, and borderline personality disorders. Dysthymic disorder was usually of early onset, predating comorbid disorders, and had often not received adequate antidepressant treatment. These results help define dysthymic disorder as prevalent, usually predating axis I comorbidity, and associated with particular axis II diagnoses.

Entities:  

Mesh:

Year:  1992        PMID: 1541768     DOI: 10.1016/0165-0327(92)90020-7

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER.

Authors:  John C Markowitz; Eva Petkova; Tatyana Biyanova; Ke Ding; Eun Jung Suh; Yuval Neria
Journal:  Depress Anxiety       Date:  2015-10-06       Impact factor: 6.505

Review 2.  Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON).

Authors:  Levente Kriston; Alessa von Wolff; Lars Hölzel
Journal:  BMC Psychiatry       Date:  2010-11-23       Impact factor: 3.630

3.  Persistent Depressive Disorder: Commentary on Parker and Malhi.

Authors:  Daniel N Klein
Journal:  Can J Psychiatry       Date:  2019-06-26       Impact factor: 4.356

4.  Latent trajectory classes of depressive and anxiety disorders from adolescence to adulthood: descriptions of classes and associations with risk factors.

Authors:  Thomas M Olino; Daniel N Klein; Peter M Lewinsohn; Paul Rohde; John R Seeley
Journal:  Compr Psychiatry       Date:  2009-08-27       Impact factor: 3.735

5.  A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.

Authors:  M F de Mello; L M Myczcowisk; P R Menezes
Journal:  J Psychother Pract Res       Date:  2001

6.  Current Perspectives on the Diagnosis and Treatment of Double Depression.

Authors:  D J Hellerstein; S A Little
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 7.  Recognition and treatment of dysthymia in elderly patients.

Authors:  S Bellino; F Bogetto; P Vaschetto; S Ziero; L Ravizza
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

8.  The long-term course of depression: development of an empirical index and identification of early adult outcomes.

Authors:  J W Pettit; P M Lewinsohn; R E Roberts; J R Seeley; L Monteith
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

9.  Course of depression in a 10-year prospective study: Evidence for qualitatively distinct subgroups.

Authors:  Daniel N Klein; Roman Kotov
Journal:  J Abnorm Psychol       Date:  2016-02-04

10.  Four cases of dysthymic disorder and general malaise successfully treated with traditional herbal (kampo) medicines: kamiuntanto.

Authors:  Toshiaki Kogure; Takeshi Tatsumi; Yuko Oku
Journal:  Integr Med Insights       Date:  2010-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.